BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 29199590)

  • 1. Regulating RNA Binding Motif 5 Gene Expression- A Novel Therapeutic Target for Lung Cancer.
    Prabhu VV; Devaraj N
    J Environ Pathol Toxicol Oncol; 2017; 36(2):99-105. PubMed ID: 29199590
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RBM5/H37 tumor suppressor, located at the lung cancer hot spot 3p21.3, alters expression of genes involved in metastasis.
    Oh JJ; Taschereau EO; Koegel AK; Ginther CL; Rotow JK; Isfahani KZ; Slamon DJ
    Lung Cancer; 2010 Dec; 70(3):253-62. PubMed ID: 20338664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The antiapoptotic RBM5/LUCA-15/H37 gene and its role in apoptosis and human cancer: research update.
    Maarabouni MM; Williams GT
    ScientificWorldJournal; 2006 Dec; 6():1705-12. PubMed ID: 17195868
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor suppressor gene RBM5 delivered by attenuated Salmonella inhibits lung adenocarcinoma through diverse apoptotic signaling pathways.
    Shao C; Yang B; Zhao L; Wang S; Zhang J; Wang K
    World J Surg Oncol; 2013 May; 11():123. PubMed ID: 23721095
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 3p21.3 tumor suppressor gene H37/Luca15/RBM5 inhibits growth of human lung cancer cells through cell cycle arrest and apoptosis.
    Oh JJ; Razfar A; Delgado I; Reed RA; Malkina A; Boctor B; Slamon DJ
    Cancer Res; 2006 Apr; 66(7):3419-27. PubMed ID: 16585163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RNA-binding motif protein 5 inhibits the proliferation of cigarette smoke-transformed BEAS-2B cells through cell cycle arrest and apoptosis.
    Lv XJ; Du YW; Hao YQ; Su ZZ; Zhang L; Zhao LJ; Zhang J
    Oncol Rep; 2016 Apr; 35(4):2315-27. PubMed ID: 26782095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The tumor suppressor gene RBM5 inhibits lung adenocarcinoma cell growth and induces apoptosis.
    Shao C; Zhao L; Wang K; Xu W; Zhang J; Yang B
    World J Surg Oncol; 2012 Aug; 10():160. PubMed ID: 22866867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lentiviral vector-mediated RBM5 overexpression downregulates EGFR expression in human non-small cell lung cancer cells.
    Su Z; Yin J; Zhao L; Li R; Liang H; Zhang J; Wang K
    World J Surg Oncol; 2014 Dec; 12():367. PubMed ID: 25441176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The two single nucleotide polymorphisms in the H37/RBM5 tumour suppressor gene at 3p21.3 correlated with different subtypes of non-small cell lung cancers.
    Oh JJ; Koegel AK; Phan DT; Razfar A; Slamon DJ
    Lung Cancer; 2007 Oct; 58(1):7-14. PubMed ID: 17606309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Candidate tumor suppressor LUCA-15/RBM5/H37 modulates expression of apoptosis and cell cycle genes.
    Mourtada-Maarabouni M; Keen J; Clark J; Cooper CS; Williams GT
    Exp Cell Res; 2006 Jun; 312(10):1745-52. PubMed ID: 16546166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Promoter methylation study of the H37/RBM5 tumor suppressor gene from the 3p21.3 human lung cancer tumor suppressor locus.
    Oh JJ; Boctor BN; Jimenez CA; Lopez R; Koegel AK; Taschereau EO; Phan DT; Jacobsen SE; Slamon DJ
    Hum Genet; 2008 Feb; 123(1):55-64. PubMed ID: 18038152
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RBM5 as a putative tumor suppressor gene for lung cancer.
    Sutherland LC; Wang K; Robinson AG
    J Thorac Oncol; 2010 Mar; 5(3):294-8. PubMed ID: 20186023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo evidence that RBM5 is a tumour suppressor in the lung.
    Jamsai D; Watkins DN; O'Connor AE; Merriner DJ; Gursoy S; Bird AD; Kumar B; Miller A; Cole TJ; Jenkins BJ; O'Bryan MK
    Sci Rep; 2017 Nov; 7(1):16323. PubMed ID: 29176597
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of RBM5 induces autophagy in human lung adenocarcinoma cells.
    Su Z; Wang K; Li R; Yin J; Hao Y; Lv X; Li J; Zhao L; Du Y; Li P; Zhang J
    World J Surg Oncol; 2016 Feb; 14():57. PubMed ID: 26923134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RBM5 inhibits tumorigenesis of gliomas through inhibition of Wnt/β-catenin signaling and induction of apoptosis.
    Jiang Y; Sheng H; Meng L; Yue H; Li B; Zhang A; Dong Y; Liu Y
    World J Surg Oncol; 2017 Jan; 15(1):9. PubMed ID: 28061901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Downregulating activated epidermal growth factor receptor has no effect on RBM5 expression.
    Masilamani TJ; Rintala-Maki ND; Wang K; Sutherland LC
    Chin Med J (Engl); 2012 Jul; 125(13):2378-81. PubMed ID: 22882865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification and characterisation of a novel antisense non-coding RNA from the RBM5 gene locus.
    Rintala-Maki ND; Sutherland LC
    Gene; 2009 Sep; 445(1-2):7-16. PubMed ID: 19559772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RBM10 promotes transformation-associated processes in small cell lung cancer and is directly regulated by RBM5.
    Loiselle JJ; Roy JG; Sutherland LC
    PLoS One; 2017; 12(6):e0180258. PubMed ID: 28662214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The 3p21.3 tumor suppressor RBM5 resensitizes cisplatin-resistant human non-small cell lung cancer cells to cisplatin.
    Li P; Wang K; Zhang J; Zhao L; Liang H; Shao C; Sutherland LC
    Cancer Epidemiol; 2012 Oct; 36(5):481-9. PubMed ID: 22609235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Down-regulated RBM5 inhibits bladder cancer cell apoptosis by initiating an miR-432-5p/β-catenin feedback loop.
    Zhang YP; Liu KL; Wang YX; Yang Z; Han ZW; Lu BS; Qi JC; Yin YW; Teng ZH; Chang XL; Li JD; Xin H; Li W
    FASEB J; 2019 Oct; 33(10):10973-10985. PubMed ID: 31318608
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.